Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06401434Not ApplicableCompleted

Evaluation of CAD-based Triage for CXR Interpretation During TB Screening

Role: lead

NCT06916962Not ApplicableRecruiting

Examining Psycho-Socioeconomic Linkages in TB Care: The UPLIFT Trial

Role: lead

NCT06191692Phase 3Not Yet Recruiting

1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam

Role: lead

NCT06221735Not ApplicableCompleted

Evaluating the Accuracy of New Tests for TB Infection Diagnosis

Role: lead

All 4 trials loaded